Brussels   |     |   Members Only

Trouble ahead? How to maintain a stable, innovative health sector in Europe


‘May you live in interesting times,’ goes the old Chinese curse. For those who want strong, well-functioning markets in Europe, we are passing through such a period: political stresses, budgetary pressures and Brexit are all conspiring to pose difficult challenges.

Join us on 8 November 2017 in Brussels for a high-level roundtable discussion – part of a search for solutions we are beginning – focusing on the challenges in the life sciences sector.

For healthcare innovation to thrive across Europe, several conditions are required. Finding new medicines and treatments requires world-class public education and research – collaborating across Europe and the world. Making medical innovations ready for market requires harmonised rules for clinical trials and authorisation, strong intellectual property protection, and deep financial markets. The last step, bringing these innovations into the clinic, has different rules from one health system to the next – but there is still immense opportunity for greater effectiveness through collaboration across Europe. All three of these steps – finding, developing and applying medical innovations – must continue strong for Europeans to remain healthy.

For more details, please contact Lysiane Pons at lysiane.pons@sciencebusiness.net

Programme
Programme

17:45 – Reception

18:15 – Welcome, Richard L. Hudson, Editor in Chief and Vice Chair, Science|Business

  • Q&A with Clare Moody, Member of the European Parliament

18:35 – How do we maintain the conditions for life sciences innovation in the EU?

  • Line Matthiessen, Director for Health, DG Research & Innovation, European Commission
  • Pascale Augé, CEO, Inserm Transfert
  • Anna Sandstrom,  Science Relations Director, AstraZeneca
  • Annemarie Haverhals, Leader, Value Based Healthcare Program, Santeon

19:15 – Dinner Debate: What are the minimum requirements for a vibrant pan-European health sector – for researchers, start-ups, pharma, doctors, administrators and patients?

21:30- Carriages

 

Featured guests
Speakers
Clare Moody
Member, European Parliament
Line Matthiessen
Acting Director, Directorate for Health, DG Research and Innovation, European Commission
Anna Sandström
EU Science Relations Director, AstraZeneca
Pascale Augé
CEO, Inserm Transfert
Annemarie Haverhals
Leader, Value Based Healthcare program, Santeon
Gian Marco Currado
Counsellor, social and environment, Permanent Representation of the United Kingdom to the EU
Nina Renshaw
Secretary General, European Public Health Alliance
Orla Sheils
Director, Trinity Translational Medicine Institute
Miguel Gonzalez-Sancho
Head of Unit, eHealth, Well-Being and Ageing, European Commission
Malcolm Harbour
Senior Advisor, CabinetDN; Former Chair, Committee on Internal Market & Consumer Affairs, European Parliament